Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related 		KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Acute myeloid leukemia 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
2 Acute myeloid leukemia 💬
 4件: BRAF, FLT3, KIT, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
3 Acute myeloid leukemia 💬
 3件: CSF1R, FLT3, KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
4 Acute myeloid leukemia 💬
 3件: CSF1R, FLT3, KIT 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
5 Acute myeloid leukemia 💬
 1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
6 Acute myeloid leukemia 💬
 1件: KIT 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
7 Acute myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
8 Acute myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
9 Acute myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
10 Acute myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
11 Acute myeloid leukemia 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
12 Acute myeloid leukemia 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
13 Adherens junction 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
14 Adherens junction 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
15 Adherens junction 💬
 2件: EGFR, ERBB2 💬 D08950 💬 Neratinib 1件: 34 💬
16 Adherens junction 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
17 Adipocytokine signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
18 Adipocytokine signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
19 Adipocytokine signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
20 Adipocytokine signaling pathway 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
21 Adrenergic signaling in cardiomyocytes 💬
 1件: SCN5A 💬 D00354 💬 Lamotrigine 5件: 13, 34, 38, 114, 144 💬
22 Adrenergic signaling in cardiomyocytes 💬
 1件: SCN5A 💬 D00358 💬 Lidocaine 13件:  6 , 13, 22, 34, 46, 51, 70, 84, 86, 107, 168, 226, 256 💬
23 Adrenergic signaling in cardiomyocytes 💬
 1件: SCN5A 💬 D08127 💬 Lidocaine 13件:  6 , 13, 22, 34, 46, 51, 70, 84, 86, 107, 168, 226, 256 💬
24 African trypanosomiasis 💬
 4件: IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
25 African trypanosomiasis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
26 AGE-RAGE signaling pathway in diabetic complications 💬
 5件: CCL2, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
27 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: CDK4 💬 D10688 💬 Abemaciclib 1件: 34 💬
28 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
29 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
30 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
31 Alcoholic liver disease 💬
 3件: IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
32 Alcoholic liver disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
33 Alcoholism 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
34 Alcoholism 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
35 Alcoholism 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
36 Alcoholism 💬
 1件: MAP2K1 💬 D11675 💬 Mirdametinib 1件: 34 💬
37 Alcoholism 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
38 Alcoholism 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
39 Alcoholism 💬
 1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
40 Allograft rejection 💬
 2件: IL10, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
41 Allograft rejection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
42 Alzheimer disease 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
43 Alzheimer disease 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
44 Alzheimer disease 💬
 4件: IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
45 Alzheimer disease 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
46 Alzheimer disease 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
47 Alzheimer disease 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
48 Alzheimer disease 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
49 Alzheimer disease 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
50 Alzheimer disease 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
51 Alzheimer disease 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
52 Alzheimer disease 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
53 Alzheimer disease 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
54 Alzheimer disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
55 Alzheimer disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 2件: 34, 65 💬
56 Alzheimer disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 4件: 26, 34, 65, 331 💬
57 Amoebiasis 💬
 4件: IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
58 Amoebiasis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
59 Amphetamine addiction 💬
 1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
60 AMPK signaling pathway 💬
 1件: HMGCR 💬 D00359 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
61 AMPK signaling pathway 💬
 1件: HMGCR 💬 D00434 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
62 AMPK signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
63 AMPK signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
64 Amyotrophic lateral sclerosis 💬
 1件: ERBB4 💬 D08950 💬 Neratinib 1件: 34 💬
65 Amyotrophic lateral sclerosis 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
66 Amyotrophic lateral sclerosis 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
67 Amyotrophic lateral sclerosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
68 Amyotrophic lateral sclerosis 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
69 Amyotrophic lateral sclerosis 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 2件: 34, 65 💬
70 Amyotrophic lateral sclerosis 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 4件: 26, 34, 65, 331 💬
71 Antifolate resistance 💬
 2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
72 Antifolate resistance 💬
 3件: IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
73 Antifolate resistance 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
74 Antigen processing and presentation 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
75 Antigen processing and presentation 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
76 Apelin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
77 Apelin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
78 Apelin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
79 Apelin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
80 Apelin signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
81 Apelin signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
82 Apelin signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
83 Apoptosis 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
84 Apoptosis 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
85 Apoptosis 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
86 Apoptosis 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
87 Apoptosis 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
88 Apoptosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
89 Apoptosis 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
90 Arachidonic acid metabolism 💬
 2件: PTGS1, PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
91 Arachidonic acid metabolism 💬
 2件: PTGS1, PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
92 Arachidonic acid metabolism 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
93 Asthma 💬
 2件: IL10, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
94 Asthma 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
95 Autoimmune thyroid disease 💬
 1件: IL10 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
96 Autophagy - animal 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
97 Autophagy - animal 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
98 Autophagy - animal 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
99 Autophagy - animal 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
100 Autophagy - animal 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
101 Autophagy - animal 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
102 Autophagy - animal 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
103 Autophagy - other 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
104 Autophagy - other 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
105 Axon guidance 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
106 Axon guidance 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
107 Axon guidance 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
108 Axon guidance 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
109 B cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
110 B cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
111 B cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
112 B cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
113 B cell receptor signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
114 Bacterial invasion of epithelial cells 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
115 Bile secretion 💬
 1件: HMGCR 💬 D00359 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
116 Bile secretion 💬
 1件: HMGCR 💬 D00434 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
117 Biosynthesis of cofactors 💬
 2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
118 Bladder cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
119 Bladder cancer 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
120 Bladder cancer 💬
 1件: CDK4 💬 D10688 💬 Abemaciclib 1件: 34 💬
121 Bladder cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
122 Bladder cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
123 Bladder cancer 💬
 2件: EGFR, ERBB2 💬 D08950 💬 Neratinib 1件: 34 💬
124 Bladder cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
125 Bladder cancer 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
126 Bladder cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
127 Bladder cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
128 Bladder cancer 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
129 Bladder cancer 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
130 Breast cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
131 Breast cancer 💬
 4件: BRAF, FLT4, KIT, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
132 Breast cancer 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
133 Breast cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
134 Breast cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
135 Breast cancer 💬
 2件: EGFR, ERBB2 💬 D08950 💬 Neratinib 1件: 34 💬
136 Breast cancer 💬
 1件: FLT4 💬 D03218 💬 Axitinib 1件: 34 💬
137 Breast cancer 💬
 1件: FLT4 💬 D08881 💬 Cediranib 1件: 34 💬
138 Breast cancer 💬
 2件: FLT4, KIT 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
139 Breast cancer 💬
 1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
140 Breast cancer 💬
 1件: KIT 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
141 Breast cancer 💬
 1件: KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
142 Breast cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
143 Breast cancer 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
144 Breast cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
145 Breast cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
146 Breast cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
147 Breast cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
148 C-type lectin receptor signaling pathway 💬
 4件: IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
149 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
150 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
151 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
152 C-type lectin receptor signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
153 C-type lectin receptor signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
154 Calcium signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
155 Calcium signaling pathway 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
156 Calcium signaling pathway 💬
 3件: EGFR, ERBB2, ERBB4 💬 D08950 💬 Neratinib 1件: 34 💬
157 Calcium signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D03218 💬 Axitinib 1件: 34 💬
158 Calcium signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D08881 💬 Cediranib 1件: 34 💬
159 Calcium signaling pathway 💬
 6件: FLT1, FLT4, KDR, PDGFRA, PDGFRB, RET 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
160 Calcium signaling pathway 💬
 4件: FLT4, KDR, PDGFRB, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
161 Calcium signaling pathway 💬
 2件: KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
162 Calcium signaling pathway 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
163 Calcium signaling pathway 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
164 Calcium signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
165 Calcium signaling pathway 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
166 cAMP signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
167 cAMP signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
168 cAMP signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
169 cAMP signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
170 cAMP signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
171 cAMP signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
172 Cell cycle 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
173 Cell cycle 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
174 Cell cycle 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
175 Cellular senescence 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
176 Cellular senescence 💬
 2件: IL1A, IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
177 Cellular senescence 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
178 Cellular senescence 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
179 Cellular senescence 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
180 Cellular senescence 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
181 Cellular senescence 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
182 Cellular senescence 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
183 Cellular senescence 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
184 Central carbon metabolism in cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
185 Central carbon metabolism in cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
186 Central carbon metabolism in cancer 💬
 2件: EGFR, ERBB2 💬 D08950 💬 Neratinib 1件: 34 💬
187 Central carbon metabolism in cancer 💬
 2件: FLT3, KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
188 Central carbon metabolism in cancer 💬
 5件: FLT3, KIT, PDGFRA, PDGFRB, RET 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
189 Central carbon metabolism in cancer 💬
 5件: FLT3, KIT, PDGFRB, RAF1, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
190 Central carbon metabolism in cancer 💬
 2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
191 Central carbon metabolism in cancer 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
192 Central carbon metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
193 Central carbon metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
194 Central carbon metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
195 Central carbon metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
196 Central carbon metabolism in cancer 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
197 Central carbon metabolism in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
198 Central carbon metabolism in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
199 cGMP-PKG signaling pathway 💬
 3件: ADRA2A, ADRA2B, ADRA2C 💬 D00514 💬 Dexmedetomidine 14件:  2 ,  4 ,  6 , 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
200 cGMP-PKG signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
201 cGMP-PKG signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
202 cGMP-PKG signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
203 cGMP-PKG signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
204 cGMP-PKG signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
205 Chagas disease 💬
 5件: CCL2, IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
206 Chagas disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
207 Chemical carcinogenesis - DNA adducts 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
208 Chemical carcinogenesis - DNA adducts 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
209 Chemical carcinogenesis - DNA adducts 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
210 Chemical carcinogenesis - reactive oxygen species 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
211 Chemical carcinogenesis - reactive oxygen species 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
212 Chemical carcinogenesis - reactive oxygen species 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
213 Chemical carcinogenesis - reactive oxygen species 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
214 Chemical carcinogenesis - reactive oxygen species 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
215 Chemical carcinogenesis - reactive oxygen species 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
216 Chemical carcinogenesis - reactive oxygen species 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
217 Chemical carcinogenesis - reactive oxygen species 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
218 Chemical carcinogenesis - reactive oxygen species 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
219 Chemical carcinogenesis - reactive oxygen species 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
220 Chemical carcinogenesis - reactive oxygen species 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
221 Chemical carcinogenesis - reactive oxygen species 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
222 Chemical carcinogenesis - reactive oxygen species 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
223 Chemical carcinogenesis - reactive oxygen species 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
224 Chemical carcinogenesis - receptor activation 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
225 Chemical carcinogenesis - receptor activation 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
226 Chemical carcinogenesis - receptor activation 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
227 Chemical carcinogenesis - receptor activation 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
228 Chemical carcinogenesis - receptor activation 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
229 Chemical carcinogenesis - receptor activation 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
230 Chemical carcinogenesis - receptor activation 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
231 Chemical carcinogenesis - receptor activation 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
232 Chemical carcinogenesis - receptor activation 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
233 Chemical carcinogenesis - receptor activation 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
234 Chemical carcinogenesis - receptor activation 💬
 1件: VDR 💬 D00188 💬 Cholecalciferol 24件:  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299 💬
235 Chemical carcinogenesis - receptor activation 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
236 Chemical carcinogenesis - receptor activation 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
237 Chemokine signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
238 Chemokine signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
239 Chemokine signaling pathway 💬
 1件: CCL2 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
240 Chemokine signaling pathway 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
241 Chemokine signaling pathway 💬
 1件: MAP2K1 💬 D11675 💬 Mirdametinib 1件: 34 💬
242 Chemokine signaling pathway 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
243 Chemokine signaling pathway 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
244 Choline metabolism in cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
245 Choline metabolism in cancer 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
246 Choline metabolism in cancer 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
247 Choline metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
248 Choline metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
249 Choline metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
250 Choline metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
251 Choline metabolism in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
252 Choline metabolism in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
253 Choline metabolism in cancer 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
254 Choline metabolism in cancer 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
255 Choline metabolism in cancer 💬
 2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
256 Choline metabolism in cancer 💬
 2件: PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
257 Cholinergic synapse 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
258 Cholinergic synapse 💬
 1件: MAP2K1 💬 D11675 💬 Mirdametinib 1件: 34 💬
259 Cholinergic synapse 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
260 Cholinergic synapse 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
261 Chronic myeloid leukemia 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
262 Chronic myeloid leukemia 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
263 Chronic myeloid leukemia 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
264 Chronic myeloid leukemia 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
265 Chronic myeloid leukemia 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
266 Chronic myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
267 Chronic myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
268 Chronic myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
269 Chronic myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
270 Cocaine addiction 💬
 1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
271 Colorectal cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
272 Colorectal cancer 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
273 Colorectal cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
274 Colorectal cancer 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
275 Colorectal cancer 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
276 Colorectal cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
277 Colorectal cancer 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
278 Colorectal cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
279 Colorectal cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
280 Colorectal cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
281 Colorectal cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
282 Coronavirus disease - COVID-19 💬
 4件: CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
283 Coronavirus disease - COVID-19 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
284 Coronavirus disease - COVID-19 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
285 Coronavirus disease - COVID-19 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
286 Coronavirus disease - COVID-19 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
287 Coronavirus disease - COVID-19 💬
 1件: TLR7 💬 D02500 💬 Imiquimod 2件: 34, 51 💬
288 Coronavirus disease - COVID-19 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
289 Cushing syndrome 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
290 Cushing syndrome 💬
 1件: BRAF 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
291 Cushing syndrome 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
292 Cushing syndrome 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
293 Cushing syndrome 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
294 Cushing syndrome 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
295 Cushing syndrome 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
296 Cushing syndrome 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
297 Cushing syndrome 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
298 Cushing syndrome 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
299 Cytokine-cytokine receptor interaction 💬
 6件: CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
300 Cytokine-cytokine receptor interaction 💬
 1件: CSF1R 💬 D11270 💬 Pexidartinib 1件: 34 💬
301 Cytokine-cytokine receptor interaction 💬
 1件: CSF1R 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
302 Cytokine-cytokine receptor interaction 💬
 1件: CSF3R 💬 D03235 💬 Filgrastim 35件:  2 ,  6 , 11, 13, 16, 22, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
303 Cytokine-cytokine receptor interaction 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
304 Cytokine-cytokine receptor interaction 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
305 Cytosolic DNA-sensing pathway 💬
 2件: IL1B, IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
306 Diabetic cardiomyopathy 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
307 Diabetic cardiomyopathy 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
308 Dilated cardiomyopathy 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
309 Dilated cardiomyopathy 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
310 Dopaminergic synapse 💬
 1件: SCN1A 💬 D00354 💬 Lamotrigine 5件: 13, 34, 38, 114, 144 💬
311 Dopaminergic synapse 💬
 1件: SCN1A 💬 D00358 💬 Lidocaine 13件:  6 , 13, 22, 34, 46, 51, 70, 84, 86, 107, 168, 226, 256 💬
312 Dopaminergic synapse 💬
 1件: SCN1A 💬 D08127 💬 Lidocaine 13件:  6 , 13, 22, 34, 46, 51, 70, 84, 86, 107, 168, 226, 256 💬
313 Dopaminergic synapse 💬
 1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
314 EGFR tyrosine kinase inhibitor resistance 💬
 3件: AXL, KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
315 EGFR tyrosine kinase inhibitor resistance 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
316 EGFR tyrosine kinase inhibitor resistance 💬
 4件: BRAF, KDR, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
317 EGFR tyrosine kinase inhibitor resistance 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
318 EGFR tyrosine kinase inhibitor resistance 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
319 EGFR tyrosine kinase inhibitor resistance 💬
 2件: EGFR, ERBB2 💬 D08950 💬 Neratinib 1件: 34 💬
320 EGFR tyrosine kinase inhibitor resistance 💬
 1件: IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
321 EGFR tyrosine kinase inhibitor resistance 💬
 1件: KDR 💬 D03218 💬 Axitinib 1件: 34 💬
322 EGFR tyrosine kinase inhibitor resistance 💬
 1件: KDR 💬 D08881 💬 Cediranib 1件: 34 💬
323 EGFR tyrosine kinase inhibitor resistance 💬
 3件: KDR, PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
324 EGFR tyrosine kinase inhibitor resistance 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
325 EGFR tyrosine kinase inhibitor resistance 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
326 EGFR tyrosine kinase inhibitor resistance 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
327 EGFR tyrosine kinase inhibitor resistance 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
328 EGFR tyrosine kinase inhibitor resistance 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
329 EGFR tyrosine kinase inhibitor resistance 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
330 EGFR tyrosine kinase inhibitor resistance 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
331 EGFR tyrosine kinase inhibitor resistance 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
332 EGFR tyrosine kinase inhibitor resistance 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬
333 EGFR tyrosine kinase inhibitor resistance 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
334 Endocrine and other factor-regulated calcium reabsorption 💬
 1件: VDR 💬 D00188 💬 Cholecalciferol 24件:  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299 💬
335 Endocrine resistance 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
336 Endocrine resistance 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
337 Endocrine resistance 💬
 1件: CDK4 💬 D10688 💬 Abemaciclib 1件: 34 💬
338 Endocrine resistance 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
339 Endocrine resistance 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
340 Endocrine resistance 💬
 2件: EGFR, ERBB2 💬 D08950 💬 Neratinib 1件: 34 💬
341 Endocrine resistance 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
342 Endocrine resistance 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
343 Endocrine resistance 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
344 Endocrine resistance 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
345 Endocrine resistance 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
346 Endocrine resistance 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
347 Endocytosis 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
348 Endocytosis 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
349 Endocytosis 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
350 Endocytosis 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
351 Endocytosis 💬
 1件: PDGFRA 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
352 Endocytosis 💬
 1件: PDGFRA 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
353 Endometrial cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
354 Endometrial cancer 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
355 Endometrial cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
356 Endometrial cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
357 Endometrial cancer 💬
 2件: EGFR, ERBB2 💬 D08950 💬 Neratinib 1件: 34 💬
358 Endometrial cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
359 Endometrial cancer 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
360 Endometrial cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
361 Endometrial cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
362 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
363 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
364 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
365 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
366 Epstein-Barr virus infection 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
367 Epstein-Barr virus infection 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
368 Epstein-Barr virus infection 💬
 2件: IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
369 Epstein-Barr virus infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
370 ErbB signaling pathway 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
371 ErbB signaling pathway 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
372 ErbB signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
373 ErbB signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
374 ErbB signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
375 ErbB signaling pathway 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
376 ErbB signaling pathway 💬
 3件: EGFR, ERBB2, ERBB4 💬 D08950 💬 Neratinib 1件: 34 💬
377 ErbB signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
378 ErbB signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametinib 1件: 34 💬
379 ErbB signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
380 ErbB signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
381 ErbB signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
382 ErbB signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
383 Estrogen signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
384 Estrogen signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
385 Estrogen signaling pathway 💬
 1件: EGFR 💬 D08950 💬 Neratinib 1件: 34 💬
386 Estrogen signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
387 Estrogen signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D11675 💬 Mirdametin